12-15 Molecular Diagnostics Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 22

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $2.5M

  • Investors
  • 1

12-15 Molecular Diagnostics General Information

Description

Provider of an on-site, rapid response diagnostic device intended for detecting and differentiating between bacterial and viral infections using biofluids. The company's target applications include testing humans and farm animals for bacterial and viral Infections, as well as agricultural products, enabling the recognition of a specific complementary target ss-DNA/RNA in a sample and providing a useful electrical signal.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 37 Panagrossi Circle
  • Suite L
  • East Haven, CT 06512
  • United States
+1 (203)
Primary Industry
Diagnostic Equipment
Corporate Office
  • 37 Panagrossi Circle
  • Suite L
  • East Haven, CT 06512
  • United States
+1 (203)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

12-15 Molecular Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Later Stage VC 10-Feb-2022 $2.5M Completed Generating Revenue
To view 12-15 Molecular Diagnostics’s complete valuation and funding history, request access »

12-15 Molecular Diagnostics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view 12-15 Molecular Diagnostics’s complete cap table history, request access »

12-15 Molecular Diagnostics Patents

12-15 Molecular Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026024616-A1 Detection of pathogenic biomarker from plant tissues using tearing and steeping methods (tsm). Pending 22-Jul-2024
WO-2025137451-A1 Apparatus and method for detection of metal ions and peas pollutants in a sample Inactive 21-Dec-2023
WO-2025054393-A1 Method and device for detecting diseases, pathogens and parasites Inactive 08-Sep-2023
US-12517084-B2 Self disinfecting sensor and method of operation Active 20-Jan-2021
US-20240077452-A1 Self disinfecting sensor and method of operation Active 20-Jan-2021 A61L2/04
To view 12-15 Molecular Diagnostics’s complete patent history, request access »

12-15 Molecular Diagnostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

12-15 Molecular Diagnostics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
CTW Venture Partners Venture Capital Minority
To view 12-15 Molecular Diagnostics’s complete investors history, request access »

12-15 Molecular Diagnostics FAQs

  • When was 12-15 Molecular Diagnostics founded?

    12-15 Molecular Diagnostics was founded in 2018.

  • Where is 12-15 Molecular Diagnostics headquartered?

    12-15 Molecular Diagnostics is headquartered in East Haven, CT.

  • What is the size of 12-15 Molecular Diagnostics?

    12-15 Molecular Diagnostics has 22 total employees.

  • What industry is 12-15 Molecular Diagnostics in?

    12-15 Molecular Diagnostics’s primary industry is Diagnostic Equipment.

  • Is 12-15 Molecular Diagnostics a private or public company?

    12-15 Molecular Diagnostics is a Private company.

  • What is the current valuation of 12-15 Molecular Diagnostics?

    The current valuation of 12-15 Molecular Diagnostics is .

  • What is 12-15 Molecular Diagnostics’s current revenue?

    The current revenue for 12-15 Molecular Diagnostics is .

  • How much funding has 12-15 Molecular Diagnostics raised over time?

    12-15 Molecular Diagnostics has raised $2.5M.

  • Who are 12-15 Molecular Diagnostics’s investors?

    CTW Venture Partners has invested in 12-15 Molecular Diagnostics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process